Production (Stage)
REGENXBIO Inc.
RGNX
$10.15
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.38% | 13.81% | 8.34% | 12.07% | 3.75% |
| Total Depreciation and Amortization | -7.69% | -6.38% | -3.41% | 3.99% | 19.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.91% | -16.62% | -7.05% | -13.85% | -12.56% |
| Change in Net Operating Assets | 184.84% | 150.82% | 123.28% | -33.17% | 148.75% |
| Cash from Operations | 56.44% | 20.73% | 16.02% | 12.36% | 17.01% |
| Capital Expenditure | 49.06% | 75.54% | 82.64% | 79.93% | 76.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.01% | -47.30% | -49.67% | -58.72% | -11.78% |
| Cash from Investing | -4.27% | -45.82% | -47.11% | -56.81% | -0.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.05% | 1,527.17% | 1,562.83% | 3,492.74% | 2,917.95% |
| Repurchase of Common Stock | 43.96% | -117.18% | -117.18% | -117.18% | -117.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 21.87% | 6.06% | -12.66% | -22.45% | -25.78% |
| Cash from Financing | -135.69% | 365.07% | 377.10% | 390.49% | 405.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.06% | 136.85% | 105.13% | 78.95% | 135.21% |